Darwin Global Management, Ltd.
An institutional investment manager in ST. HELIER. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1839209.
- Reported value$3.76bn
- Positions5
Holdings: 5 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Revolution Medicines IncRVMD | COM | 76155X100 | 2,048 | 54.5% | 10,629,822 | Added+8,418,804 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 674 | 17.9% | 6,431,163 | Reduced−10,374,021 | |
| Belite Bio IncBLTE | SPONSORED ADS | 07782B104 | 457 | 12.1% | 3,077,219 | Added+19,807 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 348 | 9.3% | 3,621,583 | Added+152,926 | |
| Roivant Sciences Ltd | SHS | G76279101 | 234 | 6.2% | 6,747,300 | Reduced−50,000 |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 0.0 | 0.0% | 0 | Sold out−17,357 |
Source: SEC EDGAR, Form 13F-HR, accession 0001892688-26-000126 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.